about
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsThe Complex Role of STAT3 in Viral InfectionsMesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in miceThe interaction of influenza H5N1 viral hemagglutinin with sialic acid receptors leads to the activation of human γδ T cells.Strategies towards universal pandemic influenza vaccines.Highly pathogenic avian influenza virus infection in chickens but not ducks is associated with elevated host immune and pro-inflammatory responses.Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD14+ cells.H5N1 Virus Hemagglutinin Inhibition of cAMP-Dependent CFTR via TLR4-Mediated Janus Tyrosine Kinase 3 Activation Exacerbates Lung Inflammation.Kolaviron Improves Morbidity and Suppresses Mortality by Mitigating Oxido-Inflammation in BALB/c Mice Infected with Influenza VirusCytokine production and signaling pathways in respiratory virus infection.The first patient recovered from avian influenza A H7N9 viral infection: A case report and review of the literatureMechanistic perspective of the oxido-immunopathologic resolution property of kolaviron in mice influenza pneumonitis.The microRNA miR-485 targets host and influenza virus transcripts to regulate antiviral immunity and restrict viral replication.Identification of NS1 domains of avian H5N1 influenza virus which influence the interaction with the NOLC1 protein.Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer.MicroRNA hsa-miR-324-5p Suppresses H5N1 Virus Replication by Targeting the Viral PB1 and Host CUEDC2
P2860
Q26800158-58EC91E4-60E3-4865-A9C5-C743F0546F8BQ26801053-8EE6CA4E-D3EB-4E39-A63D-7CE56F3ECAA3Q28596834-564C092C-CD1E-4D77-A11E-8C309398158CQ30352587-E471A9E3-DBB8-4679-B4A1-E59B3690A421Q30382226-71F62607-8042-4ADE-8D60-A6406B9D77AAQ34582210-D86A8FC5-A8AD-42D4-8616-6B1126D23CBCQ35130310-D2A1197D-71F8-4894-B1AA-8E35335E902CQ35707109-A4011CE9-7A8E-4493-9F0F-636F8D650FE8Q36030321-3ADD40EF-3C06-40D1-A2A6-CE445C2703DAQ37176690-E022E196-5140-4531-B18C-CD4B6BDF526EQ38510274-A04AE6F5-DA0F-49EA-B8C3-E12AC7E8DEF6Q39002769-32EA3377-473B-47FF-9641-8471BB4294E7Q40879529-172EE9C2-E5E9-4359-BC61-0D0FD3548EAAQ41488638-2224D436-8332-420E-9DA2-750F27467D85Q55346145-2813E3A7-AA26-4B74-A3D0-2C866661068AQ57093661-DFF5F6EF-0A04-476C-A20C-957D64106698
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Innate immunity to H5N1 influenza viruses in humans.
@ast
Innate immunity to H5N1 influenza viruses in humans.
@en
type
label
Innate immunity to H5N1 influenza viruses in humans.
@ast
Innate immunity to H5N1 influenza viruses in humans.
@en
prefLabel
Innate immunity to H5N1 influenza viruses in humans.
@ast
Innate immunity to H5N1 influenza viruses in humans.
@en
P2860
P356
P1433
P1476
Innate immunity to H5N1 influenza viruses in humans.
@en
P2860
P304
P356
10.3390/V4123363
P5008
P577
2012-12-01T00:00:00Z